This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

We take a look at an All Ordinaries share that outperformed the index, and itself, today.

Key points
  • ASX All Ordinaries healthcare share Ebos outperformed the index today 
  • The company's share price is trading at an all-time high 
  • The All Ordinaries Index slipped 0.89% in today's trade 

The All Ordinaries Index (ASX: XAO) fell 0.89% today. But this share bucked the trend to leap higher.

The Ebos Group Ltd (ASX: EBO) share price climbed 1.76% today to close at a yearly high $41.57.

Let's take a look at the Ebos Group in more detail.

Four people on the beach leap high into the air.

Image source: Getty Images

What does this ASX All Ordinaries share do?

Ebos is a marketer, wholesaler and distributor of healthcare, medical, animal care and pharmaceutical products in Australia, New Zealand and South East Asia.

Healthcare represents 87% of the company's business, with the other 13% of the company devoted to animal care.

Ebos shares are currently trading at an all-time high.

In a recent investor presentation, Ebos highlighted it makes over 12 million deliveries a year to healthcare providers and end markets.

Ebos reported $10.7 billion in revenue in the 2022 financial year. While underlying net profit after tax (NPAT) lifted 21.3% to $228.2 million.

The company delivered a final dividend of NZ 49 cents per share in FY22. Overall in FY22, Ebos delivered 96 cents per share of dividends to investors, up 8.5% on the previous year.

Ebos has acquired 20 companies since 2014. In May, Ebos acquired LifeHealthcare, one of the largest medical device distributors in Australia, New Zealand and South East Asia. Ebos sees this acquisition as an expansion opportunity. Commenting on this acquisition in November, Ebos said: "The LifeHealthcare acquisition established our presence in Southeast Asia and opens other potential opportunities in the region."

Ebos share price snapshot

The Ebos share price has climbed 4.45% in the last year. Meanwhile, Ebos shares are up 8.54% year to date. The All Ords share has a market capitalisation of $7.78 billion.

For perspective, the ASX All Ordinaries Index has shed 8.2% in the past year and 7.48% in the year to date.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two colleagues looking at a graph and comparing share prices.
Healthcare Shares

CSL shares: Buy, hold, or sell?

The shares have recovered sharply, so I wanted to see whether the valuation still stacks up.

Read more »

Two colleagues looking at a graph and comparing share prices.
Healthcare Shares

Telix vs Clinuvel Pharmaceuticals: Which ASX healthcare share deserves your next $1,000 of investment capital?

We compare Telix and Clinuvel Pharmaceuticals on valuation, dividends, and momentum—which ASX healthcare stock looks more compelling now?

Read more »

Numerous Australian dollar notes laid out.
Healthcare Shares

I'd buy 6,462 shares of this ASX stock to aim for $200 a month of passive income

This business can provide very healthy dividends.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

UBS thinks Telix Pharmaceuticals shares will go how high?

Good news out of the US has led to a share price target upgrade.

Read more »

Scientist taking down notes from a tablet, with two other scientists working in the background.
Healthcare Shares

Healius vs Australian Clinical Labs: Which ASX pathology share wins?

Healius and Australian Clinical Labs are both top pathology providers, but one stands out for profits, dividends, and recent momentum.

Read more »

Doctor looks at a graph on a tablet.
Healthcare Shares

Ramsay Health Care vs Sonic Healthcare: Which healthcare stock is better value?

Which offers better value — Ramsay Health Care or Sonic Healthcare? I compare their fundamentals, dividends, momentum and reveal my…

Read more »

A doctor looks unsure.
Healthcare Shares

CSL shares jump 93%: Is the ASX biotech stock a buy, sell or hold for October?

Can the CSL share price rebound keep going?

Read more »

Two doctors having a discussion about a patient diagnosis, holding digital tablet.
Healthcare Shares

Are CSL shares a buy after its big news?

I look at what CSL’s latest drug development deal could mean for the healthcare giant’s long-term growth.

Read more »